Nebulized ipratropium bromide in acute pediatric asthma: does it reduce hospital admissions among children presenting to the emergency department?
Rowe
B H
BH
Division of Emergency Medicine and The Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada. brian.rowe@ualberta.ca
Travers
A H
AH
Holroyd
B R
BR
Kelly
K D
KD
Bota
G W
GW
D000208:Acute Disease; D000280:Administration, Inhalation; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D004638:Emergency Treatment / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D009241:Ipratropium / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D016239:MEDLINE; D008297:Male; D015201:Meta-Analysis as Topic; D009330:Nebulizers and Vaporizers; D010343:Patient Admission / Q000706:statistics & numerical data*; D016896:Treatment Outcome
D001993:Bronchodilator Agents; D009241:Ipratropium